Last reviewed · How we verify
NCT06734676
fMRI-guided Transcranial Magnetic Stimulation Treatment for Parkinson's Disease
NA trial testing Intermittent theta burst stimulation (iTBS) in Parkinson's Disease in 36 participants. Completed in 15 May 2024.
28 April 2024
Quick facts
| Lead sponsor | Changping Laboratory |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | basic science |
| Enrollment | 36 |
| Start date | 29 May 2023 |
| Primary completion | 28 April 2024 |
| Estimated completion | 15 May 2024 |
| Sites | 1 location across China |
Drugs / interventions tested
- Intermittent theta burst stimulation (iTBS)
Conditions studied
- Parkinson's Disease — all drugs for Parkinson's Disease →
Sponsor
Changping Laboratory
Who can join
Adults 18 to 75, any sex, with Parkinson's Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to compare the efficacy of targeting the newly discovered SCAN versus traditional effector-specific networks in M1 using multimodal imaging and rTMS in patients with Parkinson's disease. The main question it aims to answer is: Is rTMS targeting the SCAN more effective than rTMS targeting effector networks?
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06734676
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Intermittent theta burst stimulation (iTBS)
Trials testing the same drug.
- NCT06902571 — Cross-validating the iTBS-induced Hemodynamic Response From fNIRS and fMRI: a Concurrent iTBS-fMRI-fNIRS Study · recruiting
- NCT06494059 — A Novel Repetitive Synchronized Associative Stimulation Neuromodulation Approach for Spinal Cord Injury Patients · NA · recruiting
- NCT05509686 — The Immediate Effects of Intermittent Theta Burst Stimulation on Intracortical Excitability of the Primary Motor Cortex · NA · completed
Other recruiting trials for Parkinson's Disease
Currently open trials in the same condition.
- NCT07115394 — EEG Measurements to Capture DBS-induced Electric Potentials · recruiting
- NCT07100171 — Evaluation of GM101 Injection in Patients With Parkinson's Disease · EARLY_PHASE1 · recruiting
- NCT06701955 — Study of the Test-retest Reliability of the Neuropsychiatric Fluctuations Scale in Parkinson's Disease · NA · recruiting
Other Changping Laboratory trials
Trials by the same sponsor.
- NCT06350396 — pBFS-guided rTMS Over DMPFC for Treatment-Resistant Depression · NA · recruiting
- NCT06255535 — pBFS Guided rTMS Over Cognitive Control Network for ASD · NA · recruiting
- NCT06255561 — pBFS Guided rTMS Over Different Targets for Treatment-Resistant Depression · NA · unknown
- NCT06166082 — Stanford Neuromodulation Therapy (SNT) for the Treatment-Resistant Depression · NA · unknown
- NCT06112652 — Neuromodulation of Different Doses to Treat TRD Guided by pBFS Technique · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06734676 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Changping Laboratory
- Last refreshed: 16 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06734676.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing